PG-synthetase inhibitors in obstetrics and after.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors; D004373:Ductus Arteriosus / Q000187:drug effects / Q000196:embryology; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy; D007213:Indomethacin / Q000009:adverse effects; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D008431:Maternal-Fetal Exchange; D011247:Pregnancy
D000893:Anti-Inflammatory Agents; D016861:Cyclooxygenase Inhibitors; D007213:Indomethacin